Accessibility Menu
 
Vaccinex logo

Vaccinex

(OTC) VCNX

Current Price$0.89
Market Cap$2.38M
Since IPO (2018)-100%
5 Year-100%
1 Year+43%
1 Month-19%

Vaccinex Financials at a Glance

Market Cap

$2.38M

Revenue (TTM)

$601.00K

Net Income (TTM)

$18.63M

EPS (TTM)

$-10.12

P/E Ratio

-0.09

Dividend

$0.00

Beta (Volatility)

1.42 (Average)

Price

$0.89

Volume

2,152

Open

$1.31

Previous Close

$0.89

Daily Range

$0.55 - $1.31

52-Week Range

$0.25 - $1.50

VCNX News

No articles available.

VCNX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vaccinex

Industry

Biotechnology

Employees

27

CEO

Maurice Zauderer, PhD

Headquarters

Rochester, NY 14620, US

VCNX Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-30%

Net Income Margin

-34%

Return on Equity

0%

Return on Capital

3%

Return on Assets

-4%

Earnings Yield

-11.11%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.38M

Shares Outstanding

2.68M

Volume

2.15K

Short Interest

0.00%

Avg. Volume

3.51K

Financials (TTM)

Gross Profit

$601.00K

Operating Income

$18.73M

EBITDA

$18.54M

Operating Cash Flow

$16.19M

Capital Expenditure

$22.00K

Free Cash Flow

$16.21M

Cash & ST Invst.

$1.11M

Total Debt

$25.00K

Vaccinex Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$213.00K

+155.2%

Gross Profit

$213.00K

+903.8%

Gross Margin

100.00%

N/A

Market Cap

$2.38M

N/A

Market Cap/Employee

$103.34K

N/A

Employees

23

N/A

Net Income

$3.37M

-1.7%

EBITDA

$3.35M

-15.5%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$1.08M

-16.0%

Accounts Receivable

$838.00K

-12.8%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$25.00K

-88.7%

Return on Assets

-3.51%

N/A

Return on Invested Capital

3.19%

N/A

Free Cash Flow

$3.93M

-9.5%

Operating Cash Flow

$3.93M

-9.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NBCONeon Bloom, Inc.
$0.01+10.76%
GRTXGalera Therapeutics, Inc.
$0.04-9.09%
ENZCEnzolytics Inc.
$0.00+0.00%
CNNACann American Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$43.87-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About VCNX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.